Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Epoetin zeta
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epoetin zeta 30,000units/0.75ml inj pre-filled syringes
0901030Q0AAAKAK
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | 13 |
|
Epoetin zeta 4,000units/0.4ml inj pre-filled syringes
0901030Q0AAADAD
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | 6 |
|
Epoetin zeta 8,000units/0.8ml inj pre-filled syringes
0901030Q0AAAGAG
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | 5 |
|
Epoetin zeta 6,000units/0.6ml inj pre-filled syringes
0901030Q0AAAFAF
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | 4 |
|
Epoetin zeta 1,000units/0.3ml inj pre-filled syringes
0901030Q0AAAAAA
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 10,000units/1ml inj pre-filled syringes
0901030Q0AAAHAH
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 2,000units/0.6ml inj pre-filled syringes
0901030Q0AAABAB
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 20,000units/0.5ml inj pre-filled syringes
0901030Q0AAAJAJ
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 3,000units/0.9ml inj pre-filled syringes
0901030Q0AAACAC
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 40,000units/1ml inj pre-filled syringes
0901030Q0AAAIAI
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 5,000units/0.5ml inj pre-filled syringes
0901030Q0AAAEAE
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.